The effect of vitamin D supplementation on uterine myoma

The effect of vitamin D supplementation on uterine myoma of women attending to hospital

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180610040046N1

Enrollment

Registered

2018-08-29

Start date

2017-03-21

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine myoma. Leiomyoma of uterus, unspecified D25.9

Interventions

Intervention 1: Intervention group: received vitamin D 50,000 IU every week for 12 weeks (Iranian Zahravi Corp.). Intervention 2: Control group: received placebo every weeks for 12 weeks (Iranian Zahr

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients who are willing to participate and consent to participate in the study Having 1-3 uterine myoma with at least 10 millimeters diameter in largest myoma according to ultrasound findings Serum level of vitamin D less than 30ng / ml

Exclusion criteria

Exclusion criteria: Consuming hormone Severe vaginal bleeding Planning for pregnancy

Design outcomes

Primary

Measure	Time frame
Size of uterine myoma. Timepoint: Before intervention and 4 months after intervention. Method of measurement: sonography.	—

Secondary

Measure	Time frame
Serum vitamin D levels. Timepoint: Before intervention and 4 months after intervention. Method of measurement: Radioimmunoassay.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Darsareh

Bandare-abbas University of Medical Sciences

famadarsareh@yahoo.com+98 67 3355 4515

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026